We then detected the level of HA in the tumor tissues by ELISA assay, and found that HA level was decreased in anti-MSLN-sP CAR-T cell treated groups compared with anti-MSLN CAR-T cell group (Figure 5F). The gene discussed is TFF2; the disease is neoplasm.